Overcoming proteasome inhibitor-refractory multiple myeloma with elotuzumab, bortezomib, nelfinavir, and dexamethasone

Alexandra Erath, Dilan A. Patel, Eric A. Hosack, James E. Patanella, Daniel M. Ibach, Adetola A. Kassim

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Fingerprint

Dive into the research topics of 'Overcoming proteasome inhibitor-refractory multiple myeloma with elotuzumab, bortezomib, nelfinavir, and dexamethasone'. Together they form a unique fingerprint.

Medicine & Life Sciences